chr2-189062866-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP2BP4_StrongBP6BS2
The NM_000393.5(COL5A2):c.1976C>T(p.Pro659Leu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000312 in 1,613,720 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. P659P) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000393.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL5A2 | NM_000393.5 | c.1976C>T | p.Pro659Leu | missense_variant, splice_region_variant | 29/54 | ENST00000374866.9 | NP_000384.2 | |
COL5A2 | XM_011510573.4 | c.1838C>T | p.Pro613Leu | missense_variant, splice_region_variant | 32/57 | XP_011508875.1 | ||
COL5A2 | XM_047443251.1 | c.1838C>T | p.Pro613Leu | missense_variant, splice_region_variant | 34/59 | XP_047299207.1 | ||
COL5A2 | XM_047443252.1 | c.1838C>T | p.Pro613Leu | missense_variant, splice_region_variant | 33/58 | XP_047299208.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL5A2 | ENST00000374866.9 | c.1976C>T | p.Pro659Leu | missense_variant, splice_region_variant | 29/54 | 1 | NM_000393.5 | ENSP00000364000.3 | ||
COL5A2 | ENST00000618828.1 | c.815C>T | p.Pro272Leu | missense_variant, splice_region_variant | 22/47 | 5 | ENSP00000482184.1 | |||
COL5A2 | ENST00000470524.2 | n.82C>T | splice_region_variant, non_coding_transcript_exon_variant | 2/8 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000356 AC: 54AN: 151810Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000498 AC: 125AN: 250984Hom.: 0 AF XY: 0.000472 AC XY: 64AN XY: 135624
GnomAD4 exome AF: 0.000307 AC: 449AN: 1461792Hom.: 1 Cov.: 33 AF XY: 0.000300 AC XY: 218AN XY: 727194
GnomAD4 genome AF: 0.000355 AC: 54AN: 151928Hom.: 0 Cov.: 32 AF XY: 0.000377 AC XY: 28AN XY: 74268
ClinVar
Submissions by phenotype
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Blueprint Genetics | Oct 08, 2015 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 05, 2024 | Variant summary: COL5A2 c.1976C>T (p.Pro659Leu) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0005 in 250984 control chromosomes. The observed variant frequency is approximately 79.69 fold of the estimated maximal expected allele frequency for a pathogenic variant in COL5A2 causing Ehlers-Danlos Syndrome phenotype (6.3e-06). To our knowledge, no occurrence of c.1976C>T in individuals affected with Ehlers-Danlos Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 155777). Based on the evidence outlined above, the variant was classified as likely benign. - |
Ehlers-Danlos syndrome, classic type, 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | May 03, 2019 | - - |
Ehlers-Danlos syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Nov 02, 2021 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 20, 2024 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 32161841, 33161638) - |
Connective tissue disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Human Genetics, Inc, Center for Human Genetics, Inc | Nov 01, 2016 | - - |
COL5A2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 18, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Familial thoracic aortic aneurysm and aortic dissection Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 14, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Ehlers-Danlos syndrome, classic type, 1 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 30, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at